Cyclobenzaprine is a commonly prescribed muscle relaxer used to treat muscle spasms, back injuries, and other musculoskeletal conditions. Many commercial drivers and safety-sensitive employees wonder whether this medication could cause a failed drug test under Department of Transportation (DOT) regulations.
The short answer is no — cyclobenzaprine is not included in the DOT drug testing panel.
However, there are still important considerations for CDL drivers and employers regarding medication safety, medical certification, and regulatory compliance.
What Drugs Does the DOT Test For?
DOT drug testing programs are regulated by the U.S. Department of Transportation and follow strict federal guidelines under 49 CFR Part 40. These regulations define exactly which substances laboratories must screen for.
DOT tests for five categories of drugs:
- Marijuana (THC metabolites)
- Cocaine metabolites
- Amphetamines and methamphetamines
- Opiates (including heroin, morphine, and codeine)
- Phencyclidine (PCP)
This is commonly referred to as the DOT five-panel drug test.
Cyclobenzaprine does not belong to any of these categories. It is a skeletal muscle relaxant and does not chemically resemble the drugs included in DOT testing.
Because of this, it will not trigger a positive DOT drug test result.
What Is Cyclobenzaprine?
Cyclobenzaprine is the generic form of the brand-name medication Flexeril. It works by acting on the central nervous system to reduce muscle spasms.
Doctors commonly prescribe it for:
- Back injuries
- Muscle strains
- Neck pain
- Post-surgical muscle spasms
Although it is not classified as a narcotic or opioid, cyclobenzaprine does have sedative effects, which can cause drowsiness or dizziness.
This is particularly relevant for commercial drivers.
Can CDL Drivers Take Cyclobenzaprine?
Yes, but there are important safety considerations.
Even though the medication does not appear on DOT drug tests, the DOT medical certification process evaluates whether a driver is medically fit to operate a commercial motor vehicle.
Some drivers may experience side effects such as:
- Drowsiness
- Reduced alertness
- Slower reaction time
- Dizziness
If these effects occur, they could make operating a commercial vehicle unsafe.
During a DOT physical exam, the medical examiner may ask about prescription medications. If cyclobenzaprine is listed, the examiner may request documentation from the prescribing physician confirming the driver can safely operate a commercial motor vehicle while taking the medication.
What Happens If Cyclobenzaprine Appears on a Drug Test?
In DOT-regulated testing, it should not appear because it is not part of the testing panel.
However, in non-DOT or expanded drug testing panels, some employers may test for additional substances. Even in those cases, cyclobenzaprine rarely triggers false positives for controlled substances.
If a laboratory screening test ever produces an unexpected result, confirmatory testing using gas chromatography/mass spectrometry (GC/MS) will identify the exact compound present.
Key Takeaways for CDL Drivers
Cyclobenzaprine will not cause a positive DOT drug test. However, drivers should still consider several factors before taking the medication while working in a safety-sensitive role.
Important points include:
- It is not included in DOT drug testing panels.
- It may cause drowsiness or sedation.
- Drivers should consult their physician before operating a commercial vehicle.
- DOT medical examiners may review prescription medications during certification.
Ultimately, the focus of DOT regulations is safety, not simply drug detection.
If a medication affects a driver’s alertness or reaction time, it could still impact their ability to perform safety-sensitive duties—even if it never appears on a drug test.